Drug Profile
WP 1048
Alternative Names: BM-32; CS-BM32-001; WP-1048Latest Information Update: 18 Feb 2022
Price :
$50
*
At a glance
- Originator Biomay
- Class Allergens; Antiallergics; Plant allergy immunotherapies; Vaccines
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Phase II Allergic rhinitis; Hypersensitivity